Elevance Health Inc.
ELV | NYSE
$420.07
-$1.95 (-0.46%)
At close: Oct 30, 2026, 4:00 PM ET
$421.02
+$0.95 (+0.23%)
Pre-market:
Nov 2, 2026, 5:15 AM ET
Company Profile
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Key Executives
| Name | Position |
|---|---|
| Gail Koziara Boudreaux | President, Chief Executive Officer & Director |
| Erin Wessling | Executive VP & Chief Legal Officer |
| Mark Bradley Kaye | Executive Vice President & Chief Financial Officer |
| Charles Morgan Kendrick Jr. | EVP and President of Commercial & Specialty Health Benefits |
| Felicia Farr Norwood | Executive VP & Chief Health Benefits Officer |
| Julie Goon | Senior Vice President of Public Affairs |
| Nathan Allen Rich | Vice President of Investor Relations |
| Peter David Haytaian | Special Advisor |
| Ronald William Penczek | Senior Vice President, Controller & Chief Accounting Officer |
| Scott Wayne Anglin | SVP, Treasurer & Chief Investment Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 10, 2026 | 8-K | Current Report |
| Sep 04, 2026 | 4 | Filing |
| Sep 04, 2026 | 4 | Filing |
| Jul 17, 2026 | 4 | Filing |
| Jul 17, 2026 | 4 | Filing |
| Jul 15, 2026 | 10-Q | Quarterly Report |
| Jul 15, 2026 | 8-K | Current Report |
| Jun 17, 2026 | 11-K | Filing |
| Jun 17, 2026 | 11-K | Filing |
| Jun 15, 2026 | 4 | Filing |
Elevance Health Inc.
| Country | United States |
| IPO Date | Oct 30, 2001 |
| Industry | Medical - Healthcare Plans |
| Sector | Healthcare |
| Employees | 96,615 |
| CEO | Gail Koziara Boudreaux |
Contact Details
220 Virginia Avenue Indianapolis,
Indiana 46204 United States
Stock Details
| Ticker Symbol | ELV |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001156039 |
| CUSIP Number | 036752103 |
| ISIN Number | US0367521038 |
| SIC Code | 6324 |
Recent News
- 2 days ago / zacks.comElevance Health (ELV) Is Up 2.73% in One Week: What You Should Know
- 6 days ago / gurufocus.comELV Fairly Valued by DCF at $418
- 7 days ago / zacks.comImplied Volatility Surging for Elevance Health Stock Options
- 11 days ago / seekingalpha.comElevance Health: Better Results, But Not Enough To Buy
- 11 days ago / fool.comElevance: 3 Key Takeaways for Long-Term Investors
- 12 days ago / zacks.comElevance Health, Inc. (ELV) Hits Fresh High: Is There Still Room to Run?
- 12 days ago / seekingalpha.comElevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript
- 12 days ago / zacks.comELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook
- 12 days ago / marketbeat.comWhat Elevance Health (ELV) Said on Its Q3 Earnings Call
- 12 days ago / zacks.comCompared to Estimates, Elevance Health (ELV) Q3 Earnings: A Look at Key Metrics
Add to Watchlist
Select watchlists to add or remove ELV